Page 81 - Haematologica-April 2018

Gfi1b in AML and MDS
Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science. 2010;327(5973):1650-1653.
41. Hole PS, Zabkiewicz J, Munje C, et al. Overproduction of NOX-derived ROS in AML promotes proliferation and is associ- ated with defective oxidative stress signal- ing. Blood. 2013;122(19):3322-3330.
42. Essers MA, Offner S, Blanco-Bose WE, et al. IFNalpha activates dormant haematopoiet- ic stem cells in vivo. Nature. 2009;458(7240):904-908.
43. Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006;12(4):446-451.
44. Bulavin DV, Fornace AJ Jr. p38 MAP kinase's emerging role as a tumor suppres- sor. Adv Cancer Res. 2004;92:95-118.
45. Park S, Chapuis N, Tamburini J, et al. Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica. 2010;95(5):819-828.
46. Sykes SM, Lane SW, Bullinger L, et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell. 2011;146(5):697-708.
47. Polfus LM, Khajuria RK, Schick UM, et al. Whole-Exome Sequencing Identifies Loci Associated with Blood Cell Traits and Reveals a Role for Alternative GFI1B Splice Variants in Human Hematopoiesis. Am J
Hum Genet. 2016;99(3):785.
48. Schulze H, Schlagenhauf A, Manukjan G,
et al. Recessive grey platelet-like syndrome with unaffected erythropoiesis in the absence of the splice isoform GFI1B-p37. Haematologica. 2017;102(9):e375-e378.
49. Vassen L, Khandanpour C, Ebeling P, et al. Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia. Int J Hematol. 2009;89 (4):422-430.
50. Sengupta A, Upadhyay G, Sen S, Saleque S. Reciprocal regulation of alternative lineages by Rgs18 and its transcriptional repressor Gfi1b. J Cell Sci. 2016;129(1):145-154.
haematologica | 2018; 103(4)
625